Literature DB >> 15882736

Postnatal unilateral pelviureteral junction obstruction: impact of pyeloplasty and conservative management on renal function.

Ahmed A Shokeir1, Mohamed T El-Sherbiny, Hosam M Gad, Mohamed Dawaba, Ashraf T Hafez, Mohamed A Taha, Mohamed Saida, Ahmed M Ghaly.   

Abstract

OBJECTIVES: To study the effect of pyeloplasty and conservative management on renal function in children with pelviureteral junction obstruction.
METHODS: This prospective study included 65 children postnatally diagnosed with unilateral pelviureteral junction obstruction. On the basis of the patients' symptoms and technetium-99m diethylenetriamine pentaacetic acid renal isotope scan findings, symptomatic patients or those with split function of the corresponding kidney of 40% or less were assigned to group 1 (n = 35) and underwent pyeloplasty. Asymptomatic patients with split function greater than 40% (group 2, n = 30) were treated conservatively. Patients who showed deterioration of renal function underwent pyeloplasty. The effect of both lines of treatment on renal function was evaluated.
RESULTS: After pyeloplasty, group 1 had improvement in the glomerular filtration rate (GFR) in 30 (85.7%), stabilization in 2 (5.7%), and deterioration in 3 (8.6%) patients. In group 1, the comparison between the mean value of the baseline GFR (17.1 +/- 7.7 mL/min) and its mean value at follow-up (28 +/- 6.3 mL/min) showed an increase of statistical significance (P <0.01). In the group 2 patients, conservative treatment resulted in improvement in the GFR in 12 (40%), stabilization in 3 (10%), and deterioration in 15 (50%) patients. In group 2, no significant difference was found between the mean baseline GFR (29.8 +/- 9.8 mL/min) and its mean value at follow-up (31.2 +/- 5.6 mL/min).
CONCLUSIONS: In patients with postnatal pelviureteral junction obstruction, early pyeloplasty is recommended if the corresponding GFR is 40% or less. Conservative management in patients with better function resulted in deterioration of renal function in 50%. Should this policy of treatment be chosen, meticulous follow-up is mandatory.

Entities:  

Mesh:

Year:  2005        PMID: 15882736     DOI: 10.1016/j.urology.2004.12.065

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  7 in total

1.  Current radiological techniques used to evaluate unilateral partial ureteral obstruction: an experimental rabbit study.

Authors:  Mehmet Yazıcı; Suleyman Celebi; Özgür Kuzdan; Hüseyin Koçan; Halil Suat Ayyıldız; İlkay Koray Bayrak; Meltem Ceyhan Bilgici; Oktay Yapıcı; Mehmet Kefeli; Ender Arıtürk
Journal:  Int Urol Nephrol       Date:  2015-05-06       Impact factor: 2.370

Review 2.  Primary non-surgical management of unilateral ureteropelvic junction obstruction in children: a systematic review.

Authors:  Marcus Weitz; Maria Schmidt; Guido Laube
Journal:  Pediatr Nephrol       Date:  2016-12-23       Impact factor: 3.714

3.  [Imaging studies in infants and children with dilatation of the upper urinary tract].

Authors:  I Körner; J D van Gool; M Ebert; F Schneble
Journal:  Urologe A       Date:  2010-03       Impact factor: 0.639

Review 4.  Is it always necessary to treat a ureteropelvic junction syndrome?

Authors:  Paul J Van Cangh
Journal:  Curr Urol Rep       Date:  2007-03       Impact factor: 3.092

5.  An initial differential renal function between 35% and 40% has greater probability of leading to normal after pyeloplasty in patients with unilateral pelvic-ureteric junction obstruction.

Authors:  Guofeng Xu; Maosheng Xu; Jianqi Ma; Zhoutong Chen; Dapeng Jiang; Zhihua Hong; Houwei Lin; Xiaoliang Fang; Liguo Wang; Lei He; Hongquan Geng
Journal:  Int Urol Nephrol       Date:  2017-08-09       Impact factor: 2.370

6.  Evaluation of UPJ obstruction before and after pyeloplasty using MR urography.

Authors:  Stephen B Little; Richard A Jones; J Damien Grattan-Smith
Journal:  Pediatr Radiol       Date:  2007-12-11

7.  Diuretic renography in hydronephrosis: renal tissue tracer transit predicts functional course and thereby need for surgery.

Authors:  Andreas Schlotmann; John H Clorius; Sandra N Clorius
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-05-13       Impact factor: 9.236

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.